Skip to main content
. Author manuscript; available in PMC: 2016 Sep 2.
Published in final edited form as: Sci Transl Med. 2016 Mar 2;8(328):328rv4. doi: 10.1126/scitranslmed.aad7118

Figure 3.

Figure 3

Mechanisms of poor tumor T cell infiltration. Active tumor β-catenin inhibits CCL4 expression and limits CD103+ DC recruitment and CD8+ T cell activation. Th1-type chemokines CXCL9 and CXCL10 are repressed by EZH2 and DNMT-mediated epigenetic silencing. Consequently CD8+ T cells poorly infiltrate tumor.